187 related articles for article (PubMed ID: 25386857)
1. Oral manifestations in the American tegumentary leishmaniasis.
da Costa DC; Palmeiro MR; Moreira JS; Martins AC; da Silva AF; Madeira Mde F; Quintella LP; Confort EM; Schubach Ade O; Silva Fda C; Valete-Rosalino CM
PLoS One; 2014; 9(11):e109790. PubMed ID: 25386857
[TBL] [Abstract][Full Text] [Related]
2. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
[TBL] [Abstract][Full Text] [Related]
3. Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
Crovetto-Martínez R; Aguirre-Urizar JM; Orte-Aldea C; Araluce-Iturbe I; Whyte-Orozco J; Crovetto-De la Torre MA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e20-6. PubMed ID: 25442251
[TBL] [Abstract][Full Text] [Related]
4. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
Motta AC; Arruda D; Souza CS; Foss NT
Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
[TBL] [Abstract][Full Text] [Related]
5. Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches.
Cruz AF; Resende RG; Albuquerque DR; de Lacerda JC; Leite CF; Ferreira Aguiar MC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):e199-e203. PubMed ID: 27234853
[TBL] [Abstract][Full Text] [Related]
6. [Mucocutaneous leishmaniasis in Morocco, evidence of the parasite's ecological evolution?].
Iguermia S; Harmouche T; Mikou O; Amarti A; Mernissi FZ
Med Mal Infect; 2011 Jan; 41(1):47-8. PubMed ID: 20947275
[No Abstract] [Full Text] [Related]
7. Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate.
Milián MA; Bagán JV; Jiménez Y; Pérez A; Scully C
Oral Dis; 2002 Jan; 8(1):59-61. PubMed ID: 11936458
[TBL] [Abstract][Full Text] [Related]
8. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report.
Machado ES; Braga Mda P; Da Cruz AM; Coutinho SG; Vieira AR; Rutowitsch MS; Cuzzi-Maya T; Grimaldi júnior G; Menezes JA
Mem Inst Oswaldo Cruz; 1992; 87(4):487-92. PubMed ID: 1343662
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
Goyonlo VM; Vahabi-Amlashi S; Taghavi F
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():177-179. PubMed ID: 31492621
[TBL] [Abstract][Full Text] [Related]
10. [Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis].
Romero GA; Lessa HA; Macêdo VO; Carvalho EM; Barral A; Magalhães AV; Orge MG; Abreu MV; Marsden PD
Rev Soc Bras Med Trop; 1996; 29(6):557-65. PubMed ID: 9011880
[TBL] [Abstract][Full Text] [Related]
11. Leishmaniasis in the genital area.
Cabello I; Caraballo A; Millan Y
Rev Inst Med Trop Sao Paulo; 2002; 44(2):105-7. PubMed ID: 12048548
[TBL] [Abstract][Full Text] [Related]
12. Retention of antimony in hair during leishmaniasis treatment.
Dorea JG; Merchan-Hamann E; Ryan DE; Holzbecher J
Clin Chim Acta; 1989 Feb; 179(3):341-5. PubMed ID: 2714007
[No Abstract] [Full Text] [Related]
13. [Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
Garcia Bustos MF; Barrio A; Parodi C; Beckar J; Moreno S; Basombrio MA
Medicina (B Aires); 2014; 74(5):371-7. PubMed ID: 25347898
[TBL] [Abstract][Full Text] [Related]
14. Mucosal leishmaniasis ("espundia" Escomel, 1911).
Marsden PD
Trans R Soc Trop Med Hyg; 1986; 80(6):859-76. PubMed ID: 3037735
[TBL] [Abstract][Full Text] [Related]
15. Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil.
Amato VS; Tuon FF; Imamura R; Abegão de Camargo R; Duarte MI; Neto VA
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1026-34. PubMed ID: 19453817
[TBL] [Abstract][Full Text] [Related]
16. Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.
Guimarães LH; Machado PR; Lago EL; Morgan DJ; Schriefer A; Bacellar O; Carvalho EM
Trans R Soc Trop Med Hyg; 2009 Jul; 103(7):712-5. PubMed ID: 19481233
[TBL] [Abstract][Full Text] [Related]
17. Voice disorders in mucosal leishmaniasis.
Ruas AC; Lucena MM; da Costa AD; Vieira JR; de Araújo-Melo MH; Terceiro BR; de Sousa Torraca TS; de Oliveira Schubach A; Valete-Rosalino CM
PLoS One; 2014; 9(7):e101831. PubMed ID: 25055046
[TBL] [Abstract][Full Text] [Related]
18. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
Sampaio RN; Marchán EM; Vexenat A; Tristão RJ; Marsden PD
Mem Inst Oswaldo Cruz; 1990; 85(3):373-4. PubMed ID: 2134714
[No Abstract] [Full Text] [Related]
19. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients.
Aliaga L; Cobo F; Mediavilla JD; Bravo J; Osuna A; Amador JM; Martín-Sánchez J; Cordero E; Navarro JM
Medicine (Baltimore); 2003 May; 82(3):147-58. PubMed ID: 12792301
[TBL] [Abstract][Full Text] [Related]
20. N-methylglucamine antimonate (SbV+): intralesional canine tegumentary leishmaniasis therapy.
Barbosa Santos EG; Marzochi MC; Conceição NF; Brito CM; Barroso JA; Pacheco RS
Parasite; 1998 Jun; 5(2):175-80. PubMed ID: 9754314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
